238 related articles for article (PubMed ID: 15771430)
1. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
Boger DL; Miyauchi H; Du W; Hardouin C; Fecik RA; Cheng H; Hwang I; Hedrick MP; Leung D; Acevedo O; Guimarães CR; Jorgensen WL; Cravatt BF
J Med Chem; 2005 Mar; 48(6):1849-56. PubMed ID: 15771430
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.
Romero FA; Du W; Hwang I; Rayl TJ; Kimball FS; Leung D; Hoover HS; Apodaca RL; Breitenbucher JG; Cravatt BF; Boger DL
J Med Chem; 2007 Mar; 50(5):1058-68. PubMed ID: 17279740
[TBL] [Abstract][Full Text] [Related]
3. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.
Lichtman AH; Leung D; Shelton CC; Saghatelian A; Hardouin C; Boger DL; Cravatt BF
J Pharmacol Exp Ther; 2004 Nov; 311(2):441-8. PubMed ID: 15229230
[TBL] [Abstract][Full Text] [Related]
4. Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Garfunkle J; Ezzili C; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Aug; 51(15):4392-403. PubMed ID: 18630870
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.
Guimarães CR; Boger DL; Jorgensen WL
J Am Chem Soc; 2005 Dec; 127(49):17377-84. PubMed ID: 16332087
[TBL] [Abstract][Full Text] [Related]
7. Correlation of inhibitor effects on enzyme activity and thermal stability for the integral membrane protein fatty acid amide hydrolase.
Slaymaker IM; Bracey M; Mileni M; Garfunkle J; Cravatt BF; Boger DL; Stevens RC
Bioorg Med Chem Lett; 2008 Nov; 18(22):5847-50. PubMed ID: 18644727
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.
Butini S; Brindisi M; Gemma S; Minetti P; Cabri W; Gallo G; Vincenti S; Talamonti E; Borsini F; Caprioli A; Stasi MA; Di Serio S; Ros S; Borrelli G; Maramai S; Fezza F; Campiani G; Maccarrone M
J Med Chem; 2012 Aug; 55(15):6898-915. PubMed ID: 22779702
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
10. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
Timmons A; Seierstad M; Apodaca R; Epperson M; Pippel D; Brown S; Chang L; Scott B; Webb M; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2008 Mar; 18(6):2109-13. PubMed ID: 18289847
[TBL] [Abstract][Full Text] [Related]
11. A second fatty acid amide hydrolase with variable distribution among placental mammals.
Wei BQ; Mikkelsen TS; McKinney MK; Lander ES; Cravatt BF
J Biol Chem; 2006 Dec; 281(48):36569-78. PubMed ID: 17015445
[TBL] [Abstract][Full Text] [Related]
12. Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH).
Min X; Thibault ST; Porter AC; Gustin DJ; Carlson TJ; Xu H; Lindstrom M; Xu G; Uyeda C; Ma Z; Li Y; Kayser F; Walker NP; Wang Z
Proc Natl Acad Sci U S A; 2011 May; 108(18):7379-84. PubMed ID: 21502526
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
[TBL] [Abstract][Full Text] [Related]
14. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
Boger DL; Sato H; Lerner AE; Hedrick MP; Fecik RA; Miyauchi H; Wilkie GD; Austin BJ; Patricelli MP; Cravatt BF
Proc Natl Acad Sci U S A; 2000 May; 97(10):5044-9. PubMed ID: 10805767
[TBL] [Abstract][Full Text] [Related]
15. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.
Ezzili C; Mileni M; McGlinchey N; Long JZ; Kinsey SG; Hochstatter DG; Stevens RC; Lichtman AH; Cravatt BF; Bilsky EJ; Boger DL
J Med Chem; 2011 Apr; 54(8):2805-22. PubMed ID: 21428410
[TBL] [Abstract][Full Text] [Related]
16. Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Kimball FS; Romero FA; Ezzili C; Garfunkle J; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Feb; 51(4):937-47. PubMed ID: 18247553
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of fatty acid amide hydrolase.
McKinney MK; Cravatt BF
Annu Rev Biochem; 2005; 74():411-32. PubMed ID: 15952893
[TBL] [Abstract][Full Text] [Related]
18. Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.
DeMartino JK; Garfunkle J; Hochstatter DG; Cravatt BF; Boger DL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5842-6. PubMed ID: 18639454
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and
Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
